Information de reference pour ce titreAccession Number: | 00005407-199608280-00033.
|
Author: | Begg, Colin PhD; Cho, Mildred PhD; Eastwood, Susan ELS-D; Horton, Richard MB; Moher, David MSc; Olkin, Ingram PhD; Pitkin, Roy MD; Rennie, Drummond MD; Schulz, Kenneth F. PhD; Simel, David MD; Stroup, Donna F. PhD
|
Institution: | From the Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY (Dr Begg); Center for Bioethics, University of Pennsylvania, Philadelphia (Dr Cho); Department of Neurological Surgery, University of California, San Francisco (Ms Eastwood); The Lancet, London, United Kingdom (Dr Horton); Departments of Medicine and Epidemiology and Community Health, University of Ottawa (Ontario) (Mr Moher); Department of Statistics, Stanford (Calif) University (Dr Olkin); Obstetrics and Gynecology, Los Angeles, Calif (Dr Pitkin); JAMA, Chicago, Ill (Dr Rennie); Centers for Disease Control and Prevention, Atlanta, Ga (Drs Schulz and Stroup); and Center for Health Services Research in Primary Care, Durham (NC) Veterans Affairs Medical Center (Dr Simel).
|
Title: | Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement.[Article]
|
Source: | JAMA. 276(8):637-639, August 28, 1996.
|
Author Keywords: | Clinical Trials; Manuscripts, Medical; Publishing; Randomized Controlled Trials; Research.
|
References: | 1. Freiman JA, Chalmers TC, Smith Jr H, Kuebler RR. The importance of beta, the type II error, and sample size in the design and interpretation of the randomized controlled trial: survey of 71 "negative' trials. N Engl J Med. 1978;299:690-694.
2. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA. 1994;272:122-124.
3. The Standards of Reporting Trials Group. A proposal for structured reporting of randomized controlled trials. JAMA. 1994;272:1926-1931. Correction: JAMA. 1995;273:776.
4. Working Group on Recommendations for Reporting of Clinical Trials in the Biomedical Literature. Call for comments on a proposal to improve reporting of clinical trials in the biomedical literature: a position paper. Ann Intern Med. 1994;121:894-895.
5. Rennie D. Reporting randomized controlled trials: an experiment and a call for responses from readers. JAMA. 1995;273:1054-1055.
6. Williams Jr JW, Holleman Jr DR, Samsa GP, Simel DL. Randomized controlled trial of 3 vs 10 days of trimethoprim/sulfamethoxazole for acute maxillary sinusitis. JAMA. 1995;273:1015-1021.
7. Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994;309:1286-1291.
8. Ad Hoc Working Group for Critical Appraisal of the Medical Literature. A proposal for more informative abstracts of clinical studies. Ann Intern Med. 1987;106:598-604.
9. Taddio A, Pain T, Fassos FF, Boon H, Ilersich AL, Einarson TR. Quality of nonstructured and structured abstracts of original research articles in the British Medical Journal, the Canadian Medical Association Journal and the Journal of the American Medical Association. Can Med Assoc J. 1994;150:1611-1615.
10. Oxman AD, Guyatt GH. A consumer's guide to subgroup analyses. Ann Intern Med. 1992;116:78-84.
11. Godfrey K. Statistics in practice: comparing the means of several groups. N Engl J Med. 1985;313:1450-1456.
12. Gardner MJ, Bond J. An exploratory study of statistical assessment of papers published in the British Medical Journal. JAMA. 1990;263:1355-1357.
13. Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB. Analysis of clinical trials by treatment actually received: is it really an option?. Stat Med. 1991;10:1595-1605.
14. Pocock SJ. When to stop a clinical trial. BMJ. 1992;305:235-240.
15. Donner A, Brown KS, Brasher P. A methodological review of nontherapeutic intervention trials employing cluster randomization, 1979-1989. Int J Epidemiol. 1990;19:795-800.
16. Schulz KF, Chalmers I, Grimes DA, Altman DG. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA. 1994;272:125-128.
17. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA. 1995;273:408-412.
18. Schulz KF. Subverting randomization in controlled trials. JAMA. 1995;274:1456-1458.
19. Schulz KF, Grimes DA, Altman DG, Hayes RJ. Blinding and exclusions after allocation in randomised controlled trials: survey of published parallel group trials in obstetrics and gynaecology. BMJ. 1996;312:742-744.
20. Karlowski TR, Chalmers TC, Frenkel LD, Kapikian AZ, Lewis TL, Lynch JM. Ascorbic acid for the common cold: a prophylactic and therapeutic trial. JAMA. 1975;231:1038-1042.
21. Pocock SJ. Clinical Trials: A Practical Approach. Chichester, England: John Wiley & Sons Inc; 1983:182-186.
22. Bailar JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Ann Intern Med. 1988;108:266-273.
23. Gardner MJ, Altman DG. Confidence intervals rather than P values: estimation rather than hypothesis testing. BMJ. 1986;292:746-750.
24. Evans M, Pollock AV. Trials on trial: a review of trials of antibiotic prophylaxis. Arch Surg. 1984;119:109-113.
25. Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. In: Gardner MJ, Altman DG, eds. Statistics With Confidence-Confidence Intervals and Statistical Guidelines. London, England: BMJ; 1989:101-108.
26. Fletcher RH, Fletcher SW. Clinical research in general medical journals: a 30-year perspective. N Engl J Med. 1979;301:180-183.
27. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996;17:1-12.
28. Altman DG. The scandal of poor medical research: we need less research, better research, and research done for the right reasons. BMJ. 1994;308:283-284.
29. Altman DG, Dore C. Randomisation and baseline comparisons in clinical trials. Lancet. 1990;335:149-153.
30. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials: a survey of three medical journals. N Engl J Med. 1987;317:426-432.
31. Gotzsche PC. Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Control Clin Trials. 1989;10:31-56. Correction: Control Clin Trials. 1989;10:356.
|
Language: | English.
|
Document Type: | Special Communication.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0098-7484
|
NLM Journal Code: | 7501160
|
Annotation(s) | |
|
|